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Mission Statement 
 
 
The mission of the Michigan Journal of Public Health is to promote public health practice, 
research, and policy with a primary focus on Michigan and the Great Lakes Region.  We 
encourage contributions from the field of practice at the state and local level, global health, 
original research, opinion and commentary.  It is the expressed interest of this Journal to 
encourage dissemination from the field of public health practice. 
 
 
Statement of Affiliation with the  
Michigan Public Health Association 
 
 
The Michigan Public Health Association (MPHA) is the organizing entity of the Michigan 
Journal of Public Health (MJPH) and is responsible for the publicizing and publication of the 
journal. The members of the Editorial Board are solicited from among public health practitioners 
and researchers, and approved by the Board of MPHA. MJPH Editorial Board members must 
also be members of MPHA and serve five year terms. 
 
 
Michigan Journal of Public Health 3 Volume 9, Issue 1 2018
  
MJPH Editorial Board 
 
 
MEMBERS: 
 
Greg Cline, PhD, School of Nonprofit and Public Administration, Grand Valley State University 
 
Connie Currier, DrPH, MPH, College of Human Medicine Program in Public Health, Michigan 
State University 
 
Vijay Kumar, MD, MPH, Department of Emergency Medicine, Wayne State University 
 
Talat Danish, MD, MPH, Dept. of Family Medicine & Public Health Sciences, Institute for 
Population Health 
 
Steven C.  Gold, MPH, Retired 
 
Dana Rice, DrPH, Dept. of Family Medicine & Public Health Sciences, Wayne State University 
 
Linda Zoeller, PhD, RN, Bronson School of Nursing, Western Michigan University 
MJPH Editor:  Greg Cline, PhD 
Michigan Journal of Public Health 4 Volume 9, Issue 1 2018
  
Author Guidelines 
 
STYLE:  
APA, 12 point font, Times New Roman, double spaced, and 1” margin. We offer a variety of 
submission categories in order to welcome a varied audience within public health.  Please see the 
required Manuscript Submission Format for submission.  Students are also encouraged to submit 
original research or public health experiences. 
SUBMISSION CATEGORIES: 
Research and Practice Articles (Up to 15 pages or 3500 words excluding references, words in 
main text, a total of 4 standard digital photographs/tables/figures, and a structured abstract of 180 
words) report the results of original quantitative and qualitative public health research. These 
may include, but are not limited to: evaluations/reports, demonstrations of innovative programs, 
best practice, exemplars/community-engaged scholarship, service learning, emerging problems, 
evidence-based practice and preliminary findings. 
Commentaries (Up to 10 pages or 2500 words in main text, 2 tables/figures, and an unstructured 
abstract of 120 words) include scholarly essays, critical analyses, and policy papers. 
Analytic Essays (Up to 15 pages or 3500 words excluding references, in main text, a total of 4 
standard digital photographs/tables/figures, and an unstructured abstract of 120 words) provide a 
forum for critical analyses of public health issues from disciplines other than the biomedical 
sciences, including, but not limited to: the social sciences, human rights, and ethics. 
Briefs (Up to 4 pages or 500 words excluding references, in main text, 2 tables/figures, and an 
abstract of up to 80 words) provide preliminary or novel findings. 
Editorials (May not exceed 1200 words) are solicited based on recommendations from the 
Editorial Board, or members of MPHA. All recommendations require approval from the MJPH 
Editorial Board. 
Letters to MJPH (Must not exceed 400 words and contain no more than 10 references) are 
encouraged by our readers. Letters may include any public health topic.  Provide a separate list, 
or refer in the text to the location of available educational materials or community tools that you 
found especially helpful. If you would like the resource posted with the electronic version, 
provide it with the submission. 
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Notes from the Field invites submissions of new or emerging issues, and underrepresented 
voices in community and public health. This category is designed to promote the exchange of 
ideas and practices amongst public health practitioners, thus, perspectives on new or effective 
community/field practices are encouraged.   “Notes” is also intended to enhance sharing insights, 
issues, innovations and new approaches to our shared problems. “Notes” will often not be 
considered research projects and are not subjected to the normal peer review process of practice 
and research articles, but may be sent for content review at the discretion of the editor.  However, 
authors should be aware that some information/data in Notes from the Field may require IRB 
and/or HIPAA review.  The manuscript should be 750 words or less in a common electronic text 
format. No more than two graphics may be included. Graphics include pictures, charts, graphs 
and tables. 
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else’s copyright. 
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CONFLICT OF INTEREST: Authors of manuscripts must reveal financial interests or connections, direct 
or indirect, that might raise the question of bias in the work reported or the conclusions, implications, or 
opinions stated, including pertinent sources of funding for the individual author(s) or for the associated 
department(s) or organization(s), personal relationships, or direct academic competition.  
The author(s) retain copyright in their work. Please select one of the following four licenses for your 
submission. 
 
NOTE FOR U.S. GOVERNMENT EMPLOYEES: If the article is single-authored by a U.S. government 
employee as part of his/her official duties, it is understood that the article is not copyrightable. Please 
select the public domain designation. It is called a “Work of the U.S. Government.” However, if the 
article was not part of the employee’s official duties, it may be copyrighted. If the article was jointly 
written, the authors understand that they are delegating the right of copyright to the nongovernment 
employee, who must sign this agreement. You must choose licensing agreement CC-O (described below). 
 
“WORK FOR HIRE” AUTHORS: If the article was written by an author who was hired by another 
person or company to do so, the article is called a “Work for Hire” manuscript. This agreement must then 
be signed by the “employer” who hired the author, as well as the author.  
 
Submitting author must choose one of the following four license options: 
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Attribution (CC-BY 4.0)   
o Anyone may share and adapt the work in any way, even for commercial purposes. Users 
agree to provide appropriate credit to the author. 
 
Attribution – Noncommercial (CC-BY-NC 4.0)  
o Anyone may share and adapt the work in any way, but may not use the material for 
commercial purposes. Users agree to provide appropriate credit to the author. 
 
Attribution – No Derivatives  (CC-BY-ND 4.0) 
o Anyone may share the work, but may not make adaptations or other derivative works.  
Users sharing the work agree to provide appropriate credit to the author. 
 
Public Domain Dedication (CC-0) 
o The creator of this work waives all of their rights in the work.  The creator wants to let 
anyone use this work in any way, for any purpose, with no restrictions.   
NOTE: Each option has a link that connects to Creative Commons. Creative Commons’ licenses 
are an easy way to inform users how to choose a license that determines how others may use, 
share, and built upon intellectual or creative work. Selecting a Creative Commons license makes 
it easier for people to use and share your work, because they don’t have to track you down, ask 
permission, and wait for your response. 
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EDITORIAL 
 
 
Michigan Cancer Consortium Celebrates 20 Years 
 
The Michigan Journal of Public Health (MJPH) invites you to celebrate 20 years of the Michigan 
Cancer Consortium (MCC) with this 2018 special issue.   
Among the core principles and values of the Michigan Public Health Association are the beliefs 
that the effective principles and practice of public health professional disciplines are central to 
the health and well-being of Michigan's people and communities. MPHA believes that diversity 
within Michigan's populations, among various cultures, and between the professional health 
disciplines enhances and enriches the public's health.  Lastly, we believe that inclusion of a 
variety of viewpoints, partnerships and teamwork involving broad representation of professionals 
and community members, and multidisciplinary interaction are essential to accomplishing 
significant improvements in the public's health. 
In alignment with our core principles, the Michigan Public Health Association has dedicated this 
special issue to Michigan Cancer Consortium’s accomplishments over the past twenty years.   
The MCC is a statewide partnership of 100 organizations working to reduce Michigan’s cancer 
burden. Its mission can best be defined by the words collaboration and partnership. This mission 
is important: cancer is the second leading cause of death in Michigan; approximately 144 people 
are diagnosed with cancer and 56 people die from the disease each day in our state. 
 
At the time it was formally established in 1998, the MCC: 
• Had 31 founding member organizations. 
• Formed its first executive committee that year. 
• Acted on priorities for cancer control in Michigan that were put into place. 
 
Today, the MCC: 
• Is nearly 100 members strong. 
• Has a sustaining structure, including a board of directors, to facilitate collaboration and 
action around priority programs and other cancer prevention and control issues. 
• Is accountable to an evidence-based cancer plan. 
• Sponsors an annual meeting that regularly draws 200 attendees. 
• Priorities for 2018-2019 include: 
o Prevention: Increase HPV vaccination rates  
o Early Detection: Increase the proportion of adults 50-75 years who are up-to-date on 
appropriate colorectal cancer screening 
o Diagnosis and Treatment: Increase the percentage of Michigan adults participating in 
cancer clinical trials 
o Quality of Life: Decrease the percent of Michigan adults diagnosed with cancer who 
report current physical pain due to cancer treatment. 
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MCC accomplishments and activities over the past 20 years include creating a dashboard as part 
of its website to track progress of MCC approved priorities, the MCC Annual Report, prostate 
cancer “Help After Treatment” guides for patients, tobacco dependence treatment partnership to 
help cancer patients, as well as receiving two national awards. 
 
We thank the leadership of the MPHA for this special edition of the MJPH highlighting the work 
of MCC. We also thank the many MCC leaders and members who invested their expertise and 
time over the last 20 years. You have been difference makers. As past leaders and members have 
done, we also will continue to lay the groundwork for the MCC’s future success. Here’s to the 
next 20 years! 
 
In health,  
Lorena Disha, MPH   Tom Rich, MPH  Dana Zakalik, MD  
President, MPHA   MCC Co-Chair  MCC Co-Chair 
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National Editorial 
The Comprehensive Cancer Control National Partnership Celebrates the 20th Anniversary 
of the National Comprehensive Cancer Control Program1 
This year marks the twentieth year that the Centers for Disease Control and Prevention (CDC) 
has supported the United States National Comprehensive Cancer Control Program (NCCCP). 
The NCCCP grew out of a movement called comprehensive cancer control (CCC), which began 
in 1994 and whose aim is to address cancer in a comprehensive manner, across the continuum of 
cancer control rather than focusing in on one cancer site (e.g. breast) or only on one aspect of 
care delivery (e.g. treatment). CCC is an approach that brings together multi-sector partners to 
collectively address the cancer burden in a community by leveraging existing resources and 
identifying and addressing cancer related issues and needs. The NCCCP began in 1998 with 
funding to six programs, including Michigan, to implement written cancer control plans through 
a statewide CCC coalition. In 1999, the Comprehensive Cancer Control National Partnership 
(CCCNP) was officially formed. This partnership brought together key federal and national 
cancer stakeholders to support both CCC programs and coalitions as they developed and 
implemented their CCC plans.  
                                                           
1 Note:  This editorial is written by the authors on behalf of the Comprehensive Cancer Control National Partnership 
https://www.cccnationalpartners.org/. The authors would like to acknowledge the leadership and contributions of the CCCNP 
Chair Cynthia Vinson, from the National Cancer Institute and Vice-Chair Frank Bright, from the National Association of Chronic 
Disease Directors.  
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In the first few years of the NCCCP, CDC and programs were working to define what CCC 
meant, how it could be useful in addressing the burden of cancer in a state, tribe or territory, and 
were often more focused on traditional public health issues like education about cancer 
prevention (tobacco, nutrition, physical activity, sun safety) and encouraging cancer screening. 
Since 1998, the NCCCP has grown from six to 66 funded programs. Now CCC programs and 
coalitions have taken a broader view of their role beyond prevention and early detection and 
have also focused on diagnosis, treatment and survivorship issues. The CCC approach has 
evolved within programs, coalitions and among national partners. Cancer plans and 
implementation of those plans now integrate advances in cancer control science and research, as 
well as place a focus on population based outcomes through policy, systems and environmental 
changes. CCC coalitions now routinely identify a set of priorities from cancer plans to focus on 
for implementation within a set period of time, increasing their ability to effectively leverage 
existing resources and focus on the “value-added” potential of the coalition – addressing issues 
that otherwise would not be addressed by one organization alone. 
The CCCNP has grown along with the NCCCP and CCC coalitions. The CCCNP officially 
formed in 1999 and now includes 19 partners. The CCCNP supports CDC’s priorities for the 
NCCCP, including: primary prevention and early detection of cancer; improving quality of life 
for cancer survivors through effective diagnosis, treatment and long-term support; focusing on 
policy changes for lasting change; promoting access to quality cancer-related care for all 
populations, and; evaluation of efforts and use of results for improvement. 
CCCNP efforts are increasingly focused on encouraging coalitions to focus on addressing the 
cancer control issues where we have strong science and can achieve significant cancer outcomes 
for populations.  These efforts include increasing human papillomavirus (HPV) vaccination 
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uptake, increasing colorectal cancer screening and addressing cancer-related disparities among 
populations, and improving the well-being of the growing population of cancer survivors in the 
US.  
Since the CCC movement began in 1994, CCC coalitions have been considered “engines of 
change” that facilitate cancer control progress across the US. The CCCNP celebrates the 
achievements of the NCCCP and CCC coalitions over the past twenty years. The Michigan CCC 
Program and the Michigan Cancer Consortium exemplify the progress made through CCC. 
Together they, along with many collaborating partners, have made significant progress in 
addressing the burden of cancer in Michigan, from development of a statewide consensus 
agreement among cancer care providers, payers, advocates, and policy makers regarding cancer 
clinical trials; to establishment of the Dr. Ron Davis Smokefree Air Law; and, establishing a 
Survivorship Care Plan Learning Collaborative for cancer centers and health systems. Perhaps 
the greatest strength of the MCC and other CCC coalitions around the country is that they keep 
people as the center of their mission. While CCC is often considered to have three foundational 
pillars: programs, partnerships and plans, there is a fourth pillar – people. Whether it is those 
whose risk is reduced by receiving a HPV vaccination or a cancer survivor whose quality of life 
is improved through participating in a wellness program for cancer survivors, people remain the 
driving force for CCC coalitions.  
As we think about the next ten to twenty years, we know that CCC programs and coalitions will 
remain important engines of change in the US. In 2018, CDC, the American Cancer Society and 
the National Cancer Institute have commissioned a study by the National Academies of Science, 
Engineering and Medicine to gather input that could lead to a national cancer control plan in the 
US. CCC coalitions are uniquely positioned to be the cornerstone of a US national cancer plan’s 
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development and implementation. The CCCNP is working to ensure CCC coalitions are that 
cornerstone and will continue to work with CCC coalitions to address the most persistent cancer 
problems. Building on the success of the NCCCP and CCC coalitions across the country, we can 
conquer cancer together.  
Authors: 
Leslie Given, BA, MPA Strategic Health Concepts 
Karin Hohman, RN, MBA Strategic Health Concepts 
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NOTES FROM THE FIELD 
An Introduction to the Priorities of the Michigan Cancer Consortium 
Polly Hager, MSN, RN 
Michigan Department of Health and Human Services,  
Cancer Prevention and Control Section 
Cancer is the second leading cause of death in Michigan. Approximately 144 people are 
diagnosed with cancer and 56 people die from cancer each day in our state. For those under 80 
years of age, cancer is the leading cause of death (Michigan Vital Records). Efforts to address 
cancer take place at many levels including federal, state, local, and organizational.  Through this 
multi-level approach all areas and populations in Michigan are targeted with interventions intended 
to reduce the impact of cancer.   
An important facet of this state’s approach to cancer is the Michigan Cancer Consortium 
(MCC). The statewide coalition consists of nearly 100 diverse member organizations that address 
cancer using an evidence-based cancer plan. Michigan’s plan reflects the cancer continuum and 
encompasses prevention, early detection, diagnosis and treatment, and quality of life. In order to 
focus its collective resources, the Consortium selected four priorities to address from 2016 through 
2018. 
The following four articles describe each priority of the MCC. The articles represent and 
are organized according to the cancer continuum, a) prevent cancer from occurring, b) promote 
early detection of cancer using tests that have been shown to reduce mortality, c) diagnose and 
treat patients using effective and appropriate methods, and d) optimize quality of life for people 
affected by cancer. 
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All articles address the efforts undertaken by workgroups assembled around each priority 
for 2016-2018 (implementation ended December 31, 2017). The work described in the articles was 
completed through collective effort. Each workgroup was led by one, or two, content experts and 
each workgroup received staff support. The contributions of content experts, staff, and workgroup 
members must be acknowledged and is critical to the successes and managing the challenges 
encountered. 
It is helpful to know that workgroups were asked to undertake projects that addressed 
health equity and/or policy, system, and environmental change related to each priority. Health 
equity and policy, system, and environmental change are two of four pillars that support the cancer 
plan and its implementation. Work plans were developed to outline the projects and the MCC 
Board of Directors approved each one prior to implementation. Workgroups provided a mid-term 
status report to the Board in early 2017. 
In the fall of 2017, the MCC Board of Directors selected four priorities for 2018 through 
2020 (implementation will end December 31, 2019). Work has begun on the new priorities and 
those activities are mentioned in varying degrees within the articles. The leadership of the MCC, 
Board of Directors, MCC member organizations, and partners are vital to the successes you will 
read about.  
This publication was supported by the Cooperative Agreement NU58DP006334 from the Centers for Disease 
Control and Prevention.  Its contents are solely the responsibility of the author and do not necessarily represent the 
official views of the Centers for Disease Control and Prevention. 
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NOTES FROM THE FIELD 
Working to Improve Human Papilloma Virus Vaccination Uptake in Michigan 
 
Courtney Cole, Michigan Public Health Institute, Angela McFall, Michigan Department of 
Health and Human Services 
 
The human papilloma virus (HPV) is a known carcinogen that causes most cervical cancers, as 
well as some cancers of the vagina, vulva, penis, anus, rectum, and oropharynx (Centers for 
Disease Control and Prevention [CDC], 2018). In Michigan, from 2010 – 2014, 1,314 people 
were diagnosed with HPV associated cancers (CDC, 2018). When identifying cancer prevention 
strategies to incorporate in the continuum of care, secondary prevention methods are the most 
common, and include cancer screenings, early detection, and progressive treatment. Vaccinations 
serve as a primary prevention method and the Food and Drug Administration (FDA) approved 
HPV Vaccine, reduces the incidence of cancer and the frequency of the virus. One of the Healthy 
People 2020 objectives is to achieve a HPV vaccine completion rate of 80% for males and 
females. Implementation of HPV evidence-based interventions and health education initiatives 
are imperative to achieve this goal.  
 
In Michigan, HPV vaccine initiation and completion rates among adolescents aged 13-17 years 
old is less than 50% (MCIR, 2018). According to researchers, identified barriers associated with 
low HPV vaccine uptake include provider hesitancy, vaccine stigma, and low uptake amongst 
the male population (Southall, 2016). In the statewide Cancer Plan for Michigan 2016-2020, the 
reduction of cervical cancer through the increase in HPV vaccination is by 2020 to: 
 
Increase the proportion of females and males ages 13-17 years who have received at least 
three doses of HPV vaccine from 24.2% (females) and 7.4% (males) to 80% (females and 
males). 
 
The Michigan Cancer Consortium (MCC) Board of Directors selected this objective as one of 
four priorities for 2016-2017, thus the MCC HPV Vaccine Priority Workgroup was assembled. 
Upon examining the data, the priority workgroup members decided to focus the work plan on 
increasing HPV vaccinations in the Hispanic population in Michigan. The work plan for the 
HPV Vaccine Priority Workgroup included conducting focus groups with the Hispanic 
population to gauge HPV and cervical cancer specific knowledge and reactions to three 
advertisements about the HPV vaccine.  
 
Focus group findings revealed women were the primary health care decision makers of the 
family and reported more sources of health information than their male counterparts. Sources of 
health information included physician contact, online health resources, friends, and family 
members. Specifically, women were interested in acquiring accurate information about the HPV 
vaccine related to dosing and age recommendations and were not aware that the vaccine could 
benefit boys as well as girls. The male focus group reported being unaware of the HPV and its 
effects on the male population. Both focus groups identified a need for Spanish language 
materials about HPV. Important aspects of communicating about HPV vaccination included 
addressing the parents, having a direct message, and making the information relatable to the 
Latino community.  
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The focus group outcomes resulted in translation of HPV public service announcements and an 
educational brochure into Spanish. A multi-media campaign using these materials was 
conducted. The campaign included radio ads on Spanish stations in Grand Rapids, Kalamazoo, 
and Big Rapids, as well as print ads in the Spanish language newspaper, Lazo Cultural. The 
MCC website includes the Spanish language resources developed during this project.  
In 2017, the HPV cancer plan objective was updated to incorporate new recommendations 
delineated by the CDC concerning dosing. In October of 2016 the CDC began recommending 2 
doses of HPV vaccine for people starting the vaccination series before their 15th birthday rather 
than the previously recommended 3 dose series. Three doses are still recommended for people 
over the age of 15 or those with immunocompromising conditions to combat cancers associated 
with HPV infections (CDC, 2016). The updated project objective is by 2020 to: 
  
Increase the proportion of females and males ages 13-17 years who have completed the 
recommended series of HPV vaccine to 80%.  
 
With the 2016-2017 project complete, the HPV Vaccine Workgroup developed a project work 
plan for 2018-2019. This work plan utilizes the CDC’s AFIX (Assessment, Feedback, Incentives, 
and eXchange) model to evaluate provider performance in offering and administering the HPV 
vaccine to clients 9-26 years old according to the current recommended vaccine schedule in five 
regions of the state. Efforts are already underway to implement the new work plan.  
This publication was supported by the Cooperative Agreement NU58DP006334 from the Centers for Disease 
Control and Prevention.  Its contents are solely the responsibility of the authors and do not necessarily 
represent the official views of the Centers for Disease Control and Prevention. 
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NOTES FROM THE FIELD 
Collaborative Efforts to Improve Cancer Survivor Quality of Life 
Audra K. Putt, MPH, CPH, Michigan Department of Health and Human Services 
 
An individual is considered a cancer survivor from the time of diagnosis through 
treatment and beyond. In Michigan, there are about 526,100 survivors (American Cancer 
Society, 2016). Survivors are living longer with the support from advancements in cancer care 
and treatment. However, they may still experience the effects of their cancer for years to come.  
 
Survivorship Care Plans (SCPs) are one way to support survivors during the transition 
from oncology care to the primary care setting. The Commission on Cancer established 
Survivorship Care Plan Standard 3.3 in which cancer programs are to, “Develop and implement 
processes to monitor the formation and dissemination of a SCP for analytic cases with Stage I, II, 
or III cancers that are treated with curative intent for initial cancer occurrence and who have 
completed active therapy” (Commission on Cancer, 2016). The SCP provides a record of 
treatment, follow-up care recommendations, referrals to support services, and additional 
community resources (Commission on Cancer, 2016).  SCPS support survivor quality of life by 
encouraging adherence to follow-up care and healthy lifestyle recommendations.  
 
In 2016, the MCC Board of Directors selected SCPs as the 2016-2017 priority under the 
Cancer Plan for Michigan’s Quality of Life Goal. The priority focuses on increasing the number 
of Michigan adults diagnosed with cancer who report receiving instructions on where to return or 
who to see for routine cancer check-ups after completing treatment. The MCC Survivorship 
Priority Workgroup, tasked with developing a project to support this effort, consists of 
professionals from different backgrounds with extensive knowledge on the needs of survivors. 
 
The MCC Survivorship Priority Workgroup determined their project would involve 
creating five SCP resource documents for post-treatment survivors. These documents would 
accompany SCPs and provide education and resources on healthy behaviors that can improve 
quality of life during survivorship. Between July 2016 and August 2017, document topics were 
selected by the workgroup based on common survivorship questions or concerns and important 
public health interventions. These topics were physical activity, nutrition, tobacco cessation, 
fatigue, and healthy lifestyle choices. The documents are not intended to replace consultation 
with a health care provider; survivors should see their health care provider for regular medical 
care. The goal is for providers to share these documents with survivors who would benefit from 
learning more about the specific topic.  
 
Since the cancer survivor population is diverse, it was determined the documents would 
be written with plain language and a reading level to accommodate survivors of various 
education levels. Plans were also set to translate the documents into two additional languages 
widely spoken in Michigan, Spanish and Arabic. The workgroup collaborated with partners in 
the Michigan Department of Health and Human Services, including the Tobacco Control 
Program, Division of Immunization, and Disability Health Unit, to review the documents that 
pertained to their content areas.  
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To test the resource documents for readability and usability, Institutional Review Board 
approval was received for a focus group with post-treatment cancer survivors. The focus group 
was organized in collaboration with St. Joseph Mercy Health System. Participants were asked to 
provide feedback on whether the five documents contained information beneficial to post-
treatment survivors and were formatted in a manner they would find appealing and easy to read. 
It was concluded from focus group feedback that resource documents of this type should include:  
• Additional resources related to the topic 
• Citations for information provided 
• Colorful pictures  
• Plain language  
• Bullet points 
Focus group feedback was helpful to ensure the documents were meeting the needs of those 
individuals their use was intended for.  
 
The five resource documents were approved by the MCC Board of Directors in 
November 2017 and made available for download on the MCC’s website (see Appendix A for an 
example of the documents). The MCC Survivorship Priority Workgroup has promoted the 
documents at the MCC Annual Meeting and through various MCC communication channels. To 
evaluate use of the documents, metrics associated with document downloads from the MCC 
website will be monitored in 2018.  
 
As the MCC Survivorship Priority Workgroup concludes their work on the SCP resource 
document project, they remain committed to improving the quality of life of Michigan cancer 
survivors. Over the next two years, the workgroup will focus on a new Cancer Plan for 
Michigan priority to reduce the percent of Michigan adults with cancer who report physical pain. 
Their project will involve creating a shared-decision making document for survivors that 
provides education on physical pain management. The workgroup and MCC are dedicated to 
meeting the unique needs of survivors as this population continues to grow.  
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NOTES FROM THE FIELD 
Increasing Colorectal Cancer (CRC) screening in Michigan 
Sharde' Burton MPH, Michigan Department of Health & Human Services 
 
Data collected by the Michigan Cancer Surveillance Program in 2014 shows that there were 
4,608 cases of colorectal cancer diagnosed and there were 1,766 deaths from the disease.   
Regular screening is one of the best ways to prevent colorectal cancer.  Screening can prevent 
colorectal cancer through the detection and removal of precancerous growths, as well as detect 
cancer at an earlier stage.  The declines in colorectal cancer incidence in recent years (about 3% 
per year from 2004-2013) have mainly been attributed to early detection (American Cancer 
Society, 2017).   
Michigan has been working to address colorectal cancer screening for over 20 years.  Recent 
efforts include: 
• Attending the first national 80% by 2018: Colorectal Cancer Forum in September 2015.  
• Developing an action plan while at the Forum to address the 80% by 2018 pledge. 
• Michigan and its Michigan Cancer Consortium (MCC) took the pledge to work towards 
a goal of screening 80% of Michigan residents for CRC by 2018.   
The Michigan Cancer Consortium’s (MCC) Colorectal Cancer Priority Workgroup 
implemented a statewide project from 2016-2017 with a goal to initiate colorectal cancer (CRC) 
screening as a quality measure for Michigan Medicaid.   CRC screening is currently a HEDIS 
measure for commercial insurance plans and Medicare.  Quality measures are tools that help 
measure or quantify healthcare processes, outcomes, patient perceptions and organizational 
structure and/or systems that are associated with the ability to provide high-quality health care 
and/or that relate to one or more quality goals for health care.   These goals include: effective, 
safe, efficient, patient-centered, equitable and timely care.  The Centers for Medicare & 
Medicaid Services (CMS) uses quality measures in its quality improvement, public reporting, 
and pay-for-reporting programs for specific healthcare providers.  
States with colorectal cancer screening as a Medicaid quality measure, such as New York, 
show increased screening rates for their members.  According to the 2013 National Health 
Interview Survey data, only 36% of Medicaid-insured adults nationwide were up to date with US 
Preventative Services Task Force colorectal cancer screening recommendations compared to at 
least 60% of privately or Medicare insured adults (Fedewa et al., 2015), while the state of New 
York had a screening rate of 59% for Medicaid insured adults in 2014 (NY State Dept. of Health, 
2015). 
The MCC Colorectal Cancer Priority Workgroup identified partners in their goal to initiate 
CRC screening as a quality measure as: key leaders with Michigan Medicaid, staff of the 
National Colorectal Cancer Round Table, leaders with the American Cancer Society Cancer 
Action Network and American Cancer Society, Inc., Lakeshore Division.  The workgroup 
drafted a letter to key leaders at Michigan Medicaid and a meeting with those leaders followed.  
The letter gave background information and recent data from studies on colorectal cancer. The 
idea that CRC screening should be a quality measure was well received, but it was recommended 
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to be presented at a later date, as the state’s amended plan was in the process of being approved 
by CMS.  The state’s amended plan would include CRC screening as a preventive benefit for 
state Medicaid members.  Upon approval of the state’s amended plan within a year after the 
initial meeting, the MCC Colorectal Cancer Priority Workgroup followed up with key leaders of 
Michigan Medicaid. While CRC screening has not yet been made a quality measure of Medicaid 
in Michigan, many efforts are currently in place to make it so and meetings with the partners 
described above continue. 
Moving forward, the Colorectal Cancer Priority Workgroup will continue its efforts to 
improve colorectal cancer screening rates in Michigan.  The workgroup will focus on proven 
intervention strategies to increase colorectal cancer screening rates.  Following are the evidence-
based interventions (EBI’s) the workgroup will focus on to increase screening rates: 
• Client reminders 
• Provider reminders 
• Reducing structural barriers 
• Provider assessment and feedback 
The workgroup will promote these evidence-based interventions among the Michigan Cancer 
Consortium member organizations through a policy, systems, and environmental (PSE) change 
project.  The combination of continued work to initiate CRC screening as a quality measure and 
implementation of a PSE change project are important efforts to increase the colorectal cancer 
screening rates in Michigan.  
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NOTES FROM THE FIELD 
 Expressway to Cancer Clinical Trials: Reducing Administrative Barriers to Enrollment 
Audra Putt, MPH, CPH, Michigan Department of Health and Human Services 
For nearly 20 years, the Michigan Cancer Consortium (MCC) has been involved in 
efforts with a variety of stakeholders to increase cancer patient participation in clinical trials. In 
2001, the MCC partnered with the Michigan Working Group to Improve Cancer Outcomes on 
the development of the Consensus Guidelines for Healthcare Coverage of Routine Patient Care 
Cost Associated with Oncology Clinical Trials. The goal of this Consensus Agreement’s creation 
was to increase participation in specific cancer-related clinical trials by supporting the 
predictability of payment for clinical trial services. The voluntary Consensus Agreement includes 
a framework detailing third party payer coverage of patient costs in relation to their benefit plan 
for clinical trial enrollment. Members of the Michigan Association of Health Plans supported the 
Consensus Agreement and agreed to increase participation in cancer-related clinical trials 
through coverage of routine costs associated with participation. A 2015 assessment supported by 
the MCC found clinical trial coverage through larger Michigan health plans (including Medicaid 
and Medicare) generally aligns with the Consensus Agreement.  
 
With changes related to health care coverage through the Affordable Care Act and 
advancements in treatment, the MCC Board of Directors selected increasing cancer clinical trial 
enrollment as the 2016-2017 priority under the Cancer Plan for Michigan’s Diagnosis and 
Treatment Goal in 2016. The MCC Clinical Trials Priority Workgroup was tasked with 
developing a project to support this effort. The workgroup convened with the goal to ensure 
Michigan residents with cancer who want to join a clinical trial can do so with fewer barriers. In 
2016, 7 percent of Michigan adults who reported a cancer diagnosis also reported participating in 
cancer treatment clinical trials (Michigan Department of Health and Human Services, 2016).  
 
The workgroup began by surveying stakeholders with the MCC and Michigan Society of 
Hematology and Oncology (MSHO) to assess barriers to clinical trial enrollment. Survey results 
indicated that providers had concerns with the sometimes-lengthy clinical trial enrollment 
process. As a result, the workgroup decided their project would address prior authorization 
concerns. Insurers often require prior authorization for cancer clinical trial enrollment, and ask 
for different pieces of information. This can lead to communication barriers between providers 
and insurers. In some instances, patient enrollment can be delayed by weeks while prior 
authorization is approved. The workgroup project focused on facilitating more rapid response to 
prior authorization requests by creating a fax cover sheet that could be shared with practitioners 
and used as a “heads up” when enrolling patients in cancer clinical trials. 
The fax cover sheet was created for use when a health insurance carrier requires prior 
authorization for participation in a cancer clinical trial. It asks for such information as why the 
patient is eligible to participate, the therapeutic purpose for conducting the trial, and whether the 
trial is federally funded (see Appendix A for the fax cover sheet). Use of the fax cover sheet 
intends to simplify the prior authorization process and reduce the time needed to prepare and 
receive approval for authorization, thus decreasing the administrative burden for providers and 
insurers. The MCC Board of Directors approved the fax cover sheet in August 2016 and made it 
available as a fillable form on the MCC Website.   
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After development of the fax cover sheet, the workgroup established a promotion plan for 
sharing it with various stakeholders and partners. Steps were taken to promote the fax cover 
sheet at the MCC Annual Meeting, on the MCC Website, at hospital cancer committee meetings, 
and with partner newsletters. Following promotion, an evaluation plan for determining the cover 
sheet’s reach was also established. In 2017, it was downloaded from the MCC website 261 times. 
Questions about knowledge and use of the fax cover sheet were included in the 2017 MCC 
Annual Survey. MSHO members were also surveyed on similar questions in the fall of 2017. 
The results from both surveys (Figure 1) indicated there is still work to be done with promoting 
the fax cover sheet.  
 Michigan Cancer Consortium 
Member Survey 
Michigan Society of 
Hematology and Oncology 
Member Survey 
Number of respondents (N=) 86 111 
Aware of the cover sheet 23 (26.7%) 21 (18.9%) 
Used the cover sheet in their 
office 
3 (3.5%) 12 (10.9%) 
Figure 1. Partner Knowledge and Use of the Clinical Trials Fax Cover Sheet Form 
 
Over the next two years, the workgroup will continue to promote cancer clinical trial 
enrollment. A new project will be undertaken by the workgroup to develop infographics for 
patients and primary care providers, detailing the benefits of clinical trial enrollment. To support 
health equity, the infographics will meet accessibility guidelines. The MCC and Clinical Trials 
Priority Workgroup will remain dedicated to providing support and resources to increase the 
number of Michigan adults with cancer who participate in cancer clinical trials.  
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Appendix A: MCC Clinical Trials Cover Sheet 
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RESEARCH & PRACTICE 
Lessons Learned from Revising the Cancer Plan for Michigan 
OVERVIEW 
The burden of cancer in Michigan is large and eliminating the burden requires a 
comprehensive approach. Cancer is the second leading cause of death in Michigan and is the 
leading cause of death for people under 80 years of age (Michigan Department of Health and 
Human Services, 2018). The American Cancer Society estimates there will be 56,590 new cases 
of cancer in Michigan and that 21,380 Michiganders will die from cancer during 2018 (Cancer 
Facts and Figures 2018, 2018). Michigan is the 10th most populous state in the country (U.S. 
Census Bureau, 2014) and has the 7th greatest number of cancer survivors, estimated at 
approximately 526,100 in 2016 (American Cancer Society, 2016). 
Comprehensive cancer control (CCC) is a collaborative way to address cancer through 
partnerships and sharing resources. The Centers for Disease Control and Prevention (CDC) funds 
state, territories, and tribal CCC programs to develop, implement, and maintain cancer plans to 
guide CCC work (National Comprehensive Cancer Control Program (NCCCP), 2017). Cancer 
plans “identify how an organization addresses cancer burden as a significant public health 
challenge. They are data-driven, evidence-based blueprints for action” (Centers for Disease 
Control and Prevention, 2018). The Comprehensive Cancer Control Implementation Building 
Blocks suggest that when CCC priorities are implemented it will lead to both short and long-term 
outcomes, one of which is decreased morbidity and mortality (Rochester, Townsend, Given, 
Krebill, & Balderrama, 2010). CDC directs each CCC program to work with its partners to develop 
their plan (Cancer Plan Self-Assessment Tool, 2013). 
The most recent version of the Cancer Plan for Michigan was in place from 2009-2015 and 
was updated periodically. But, given the rapidly advancing science of cancer care and population 
health interventions, by 2015 the plan no longer fully reflected state-of-the-art cancer research and 
innovations. In order for Michigan’s Cancer Plan to direct CCC priorities and activities in the state, 
revisions were needed. To address this problem, Michigan developed and completed a process to 
update its Cancer Plan. The CCC program used its long-term experience, expertise, and network 
of partners to guide the necessary revision of the Cancer Plan (Hager, Given, Redmond, & Rogers, 
2010) (Miller, Hager, Lopez, Salinas, & Shepherd, 2009). The objectives of this article are to 
describe the revision and implementation of the Cancer Plan for Michigan, to outline community 
engagement efforts and stakeholder involvement in the process, and to present outcomes of the 
cancer plan revision process. 
DESCRIPTION 
 Michigan’s CCC Program is coordinated and staffed by the Michigan Department of 
Health and Human Services (MDHHS), which also supports its partner, the Michigan Cancer 
Consortium (MCC). The MCC is a network of approximately 100 dedicated public, private, and 
voluntary organizations that implement cancer plan activities. The coalition includes members that 
represent the following organizational categories: health systems, insurance plans, local health 
departments, research institutions, universities, trade organizations and special population groups. 
While these organizations may have varied interests, working together through the MCC they 
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share resources and knowledge, reduce duplicative efforts, maximize resource use and develop 
strategic attacks against the cancer burden in Michigan.  
 
With a diverse representation of member organizations, the MCC collectively serves a wide 
array of populations throughout the state of Michigan. In the 2017 MCC Annual Survey, 77% of 
member organizations (n = 86) reported serving people with lower socioeconomic status, 72% 
reported serving the black or African American population, 62% reported serving people of 
Hispanic/Latino ethnicity, 58% reported serving people with a disability, 57% reported serving an 
Asian and Arab/Middle Eastern population, and 55% reported serving the Native American 
population. MCC members also reported that they serve the lesbian, gay, bisexual, and transgender 
community and refugees. Michigan has a mix of urban, suburban, and rural communities. 
Approximately 74% of MCC members serve both rural and urban areas, 7% serve rural areas 
exclusively, and 11% serve urban communities exclusively. 
 
The diversity of MCC organizations and the expertise of its members offers unique 
opportunities for Michigan’s Cancer Plan implementation. Coalitions have an understanding and 
belief that the cancer burden will decline through successful coordinated action (Rochester, 
Townsend, Given, Krebill, & Balderrama, 2010). Michigan has made significant progress toward 
the achievement of many goals and objectives since beginning its CCC work with the CDC (True, 
Kean, Nolan, Haviland, & Hohman, 2005). Table 1 shows examples of the evolution of the Cancer 
Plan objectives over the lifetime of the MCC. The MCC member organizations engaged in and 
reported on multiple cancer control activities and these efforts were monitored and evaluated to 
determine progress and impact. Still, given advances in the field of cancer control a fully revised 
cancer plan was needed to direct the state’s cancer control activities for the next five years.  
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Table 1. The evolution of objectives over the history of Michigan’s Caner Plans. 
 1998-2002 2009-2015 2016-2020 
Colorectal 
Cancer 
Screening 
By 2004, increase to 50 percent 
the proportion of average-risk 
people with a life expectancy of 
at least five years who have 
received appropriate colorectal 
cancer screening.  (Baseline: 
17.3 percent of people in 1992) 
By 2015, increase to 
75 percent the 
proportion of average-
risk people in 
Michigan who report 
having received 
appropriate colorectal 
cancer screening and 
follow-up of 
abnormal screening 
results. 
 
Increase the 
proportion of adults 
aged 50 to 75 years 
who are up-to date on 
appropriate colorectal 
cancer screening from 
71% to 80%.19 
End-of-
life Care 
By 2005, increase the timeliness 
of referrals to end-of-life 
services for breast, cervical, 
colorectal, lung, and prostate 
cancer patients.   
By 2015, increase 
cancer patients’ and 
caregivers’ 
understanding of 
options for:  1) care up 
to, and during, the last 
phase of life, and 2) 
pain and symptom 
relief. 
Decrease the number 
of Michigan adult 
cancer patients who 
are enrolled in hospice 
within 3 days of their 
death from 14.3% to 
14% 
 
 
Michigan’s objective of revising the cancer plan was to create an updated blueprint to guide 
CCC work in the state. Building on the strong foundation in place for comprehensive cancer 
control in Michigan, two key outcomes of interest were identified for the strategy to revise the 
Cancer Plan for 2016-2020: 1) create a plan that meets criteria outlined by the MCC Evaluation 
Committee and 2) revise the plan using an efficient strategy that offers multiple venues for 
stakeholder participation.  
 
In the fall of 2014, one year prior to when the 2009-2015 Cancer Plan came to a close, the 
MCC convened its Evaluation Committee, a group of stakeholders with expertise in evaluation, to 
guide and facilitate the revision process. The MCC Evaluation Committee, with support from 
expert consultants, developed the plan structure, revision process and timeline, and presented them 
to the MCC Board of Directors for approval. The evaluation committee represented the planning 
level of stakeholder input while the MCC Board of Directors represented the decision-making 
level of stakeholder input. 
 
The first step to determine desirable parameters for the Michigan Plan was to look at cancer 
plans from other CCC programs, including Minnesota and New York. The Evaluation Committee 
recommended the following for Michigan’s Cancer Plan content, layout, and features: 
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1. Reduce the overall length of the Cancer Plan to less than 50 pages. 
2. Align the overarching goals with the continuum of cancer care. 
3. Limit the number of objectives and strategies under each goal area. 
4. Use common criteria to select the objectives and strategies while ensuring they are data 
driven and evidence based.  
 
In January and February 2015, CCC staff reviewed the existing Cancer Plan to assess how 
it compared with recommendations set forth by the Evaluation Committee. The assessment 
revealed that the Cancer Plan was 100 pages above the recommended length, had 14 goals, none 
of which were aligned with the continuum of cancer care, and none of the objectives were specific, 
measurable, achievable, relevant, and timely (SMART).  
 
During the same time period, the Evaluation Committee narrowed down the goals for the 
Cancer Plan to four modeled after the national CCC program priorities (Centers for Disease 
Control and Prevention, 2017): 
 
1. Prevent cancer from occurring. 
2. Promote early detection of cancer using tests that have been shown to reduce mortality. 
3. Diagnose and treat all patients using the most effective and appropriate methods.  
4. Optimize quality of life for every person affected by cancer. 
 
The Evaluation Committee considered including health equity; policy, systems, and 
environmental changes; active partnerships; and continuous evaluation as goals. However, since 
these principles can be applied across the full continuum of cancer care, the Committee established 
them as “pillars”-- overarching concepts that should be incorporated into implementation of the 
Cancer Plan. Once the goals and pillars were defined, the Committee developed a systematic 
process that included ways to engage MCC members in the revision. 
 
After the Board of Directors approved the process in March 2015, the MCC created four 
workgroups, one to address each goal for the revised Cancer Plan. Workgroups consisted of two 
co-chairpersons, one MDHHS staff person and one subject matter expert from the MCC. 
Individual MCC members volunteered to participate in the workgroups. The number of members 
in each workgroup ranged from 12 to 21. The co-chairs for each workgroup held a planning session 
by phone prior to the first meeting of their group.  
 
In order to develop plan objectives, MDHHS staff compiled a list of topics each goal might 
include. For example, the goal related to prevention of cancer included topics such as healthy 
eating, physical activity, HPV vaccination, tobacco use, and alcohol use. MDHHS staff developed 
worksheets with a list of potential SMART objectives for each topic. Every objective was linked 
to a consistent data source and included baseline data, if available.  
 
Workgroups were given instructions (Figure 1) which outlined the revision process. In 
April 2015 the workgroups met over teleconference and used a worksheet (Figure 2) to narrow 
down the list of objectives using common criteria and to determine a realistic target to achieve for 
each objective by 2020.  
Figure 1. Guidance for updating the Michigan Cancer Plan. This figure illustrates the guidance document 
outlining the revision process of the Cancer Plan for Michigan. 
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Figure 1. Guidance for updating the Michigan Cancer Plan. This figure illustrates the guidance document 
outlining the revision process of the Cancer Plan for Michigan. 
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Figure 2. Worksheet for selecting objectives. This figure illustrates the worksheet used by Cancer Plan 
workgroups to select the objectives that would be included in the Cancer Plan for Michigan. 
 
Once the workgroups had a final list of objectives, MDHHS staff researched evidence-
based strategies for each objective. In May 2015, a second teleconference meeting was held with 
each workgroup to choose the final list of strategies for each objective. A worksheet with criteria 
for choosing strategies was used to narrow down the list. At the end of the revision process, there 
were 36 objectives and 111 strategies across the 4 goals. The final objectives and strategies were 
vetted by the Evaluation Committee and then approved by the Board of Directors in June 2015.  
Although the plan covers the full cancer continuum, it was recognized that the MCC is not 
able to actively work on all 36 objectives. In order to be more strategic in implementing the plan, 
the MCC involved its partners in a process to select priorities. It was a deliberate decision to 
prioritize one objective in each goal area so the full cancer continuum is represented. Many 
stakeholders were involved in the prioritization process. Workgroup members completed an online 
survey to vote on the top two priority objectives within their goal. The objectives that received 
more than 50% of the votes were reviewed by the Evaluation Committee and presented to the 
Board of Directors in September 2015. The Board of Directors, the Evaluation Committee, and 
workgroup co-chairs discussed the feasibility and impact of achieving those objectives, and then 
the Board of Directors voted to determine the final four priority objectives. The MCC focused its 
efforts on the priority objectives during the first two years of the Cancer Plan, 2016 through 2017.  
DISCUSSION AND EVALUATION 
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The first goal of Michigan’s cancer plan revision process was to create a plan that meets 
the criteria outlined by the MCC Evaluation Committee. This goal was achieved, as evidenced by 
the Cancer Plan available on the MCC’s website, www.michigancancer.org (Michigan Cancer 
Consortium, 2017). Michigan’s Cancer Plan for 2016-2020 is a 27-page document, well below the 
50-page recommendation, that includes 36 SMART objectives across the four goal areas and each 
objective has a list of suggested evidence-based strategies. As previously described, the cancer 
plan goal areas are aligned with the cancer continuum. Worksheets and specific selection criteria 
were used to guide selection of objective and strategies. This planning and structure worked well 
to shape workgroup conversations and efficiently use workgroup members’ time. The structure 
allowed workgroup members to suggest cancer plan topics not included in the prepared worksheets 
and the pre-established selection criteria kept those workgroup discussions focused. 
 However, this structure presented a few key challenges. The planning and worksheet 
preparation was time intensive for the MDHHS staff supporting the cancer plan revision process. 
Also, it was difficult to apply the same standards across the cancer continuum. Some areas had a 
wealth of established resources, such as The Guide to Community Preventive Services (The 
Community Guide) (Community Preventive Services Task Force, n.d.), while in other areas the 
science was just emerging so the level of evidence and ease of locating evidence was different. For 
example, there were extensive data and a large selection of Healthy People 2020 (U.S. Department 
of Health and Human Services, 2018) objectives and Community Guide strategies available for 
reference for most suggested topics in the prevention and early detection goal areas. The largest 
task for the prevention and early detection workgroups was to narrow the focus and select the most 
important objectives and strategies to improve the health of Michiganders. The diagnosis and 
treatment and quality of life workgroups had the opposite problem. Healthy People 2020 and the 
Community Guide offered minimal suggestions for objectives and strategies in these areas. In 
addition, there were limited statewide data in these areas, which restricted possibilities for SMART 
objectives. 
 Creating a cancer plan with SMART objectives highlighted that most public health data 
sources have limits in their ability to depict the needs of certain Michigan populations. Health 
equity was one of the pillars that all workgroups were asked to incorporate into the objectives. 
However, most statewide data was not consistently available for sub-populations, which limited 
the ability to demonstrate health disparities. In an effort to tackle this issue, after the completion 
of the Cancer Plan, Michigan began a process to identify additional data sources to better measure 
public health interventions across the cancer continuum for all Michigan populations.  
The second goal was to use an efficient revision strategy that offered multiple venues for 
coalition stakeholder participation. The MCC requested volunteers to shape the Cancer Plan for 
Michigan around the four cancer continuum goal areas. This solicitation for volunteers differed 
from past processes because experts on a wide variety of topics were solicited at once. Still, a 
sufficient number of members were recruited for the workgroups. Some workgroup volunteers 
were active in the MCC and some had not been actively engaged prior to this cancer plan revision 
process. The revision process provided all MCC members an opportunity to offer their expertise 
along the full cancer continuum. Workgroup members were able to provide input on Cancer Plan 
objectives and strategies during multiple conference calls that were scheduled based on member 
availability. Workgroup members were also able to provide feedback by email throughout the 
process.  
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Thanks to a straightforward process and great stakeholder participation, Michigan now has 
a measurable cancer plan and a clear strategy for monitoring progress towards achieving the plan 
objectives (Michigan Cancer Consortium, 2017). Having such a structured, concise cancer plan 
and timing its release with the MCC Annual Meeting in November 2015 helped engage leaders, 
including national leaders, state government administration, and state health department 
leadership, in the release of the Cancer Plan while also bringing it to their attention. Moving 
forward, Michigan is adapting and applying the process used to revise the cancer plan, including 
the commitment to methodical preparation, to the MCC’s Cancer Plan implementation activities. 
  
The structured process that Michigan used to revise the state Cancer Plan resulted in a data driven 
plan created with involvement from a large number of stakeholders from across the state and across 
sectors. The process involved the development of guidance documents with criteria for the 
stakeholder workgroups to use when making decisions. It also involved worksheets to lay out 
potential cancer plan objectives and strategies and help workgroup members use the decision 
criteria to select objectives and strategies. This helped structure workgroup meetings and email 
communications and facilitated an efficient and transparent decision making process.  
 
NEXT STEPS 
There are a few things that will be done the next time the cancer plan is revised. First, 
provide clear written guidance on what it will mean to incorporate the cancer plan pillars of policy, 
systems, and environmental change, health equity, active partnerships, and evaluation, into the 
cancer plan objectives and strategies. While the pillars were stated and considered in the process 
of creating the 2016-2020 plan, there was no clear guidance on how to incorporate them into the 
plan.  
 
Second, put in place a formal process to gather input from statewide chronic disease 
program partners. Given existing collaborative relationships, a few staff from other chronic disease 
programs in Michigan participated in the cancer plan workgroups but there is opportunity for more 
engagement in the future. 
 
Third, have an evaluation plan to determine stakeholder satisfaction with the process. 
While MDHHS staff have received informal positive feedback, there was no official evaluation 
system in place.  
 
The structured process and supporting guidance document and worksheets that Michigan 
used facilitated effective engagement of a broad base of stakeholders and resulted in a Cancer Plan 
that met the pre-established criteria. The staff anticipate that with some adaptations the process 
will continue to work well in the future. The authors encourage other CCC programs that use other 
stakeholder engagement and cancer plan revision processes to share their experiences. 
 
KEY FINDINGS 
• A structured process helped involve a wide array of public and private stakeholders and 
allowed participation at every step of the process. 
• An emphasis on data and evidence-based strategies resulted in a measurable cancer plan 
and a clear strategy for monitoring progress towards achieving the plan objectives. 
• Evaluating every step of the process is needed to determine its success and efficacy.  
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RESEARCH & PRACTICE 
Evaluating the Needs of Cancer Survivors through Focus Groups and Surveillance Data 
Introduction 
 
Cancer is the second leading cause of death in the United States, therefore, much of the research 
focuses on its prevention and treatment. As these prevention methods and treatments improve, 
the survival rates for most cancers continue to rise. The American Cancer Society (ACS) 
estimated that there were 526,100 cancer survivors in the state of Michigan in 2016 (American 
Cancer Society [ACS], 2016).  A person is considered a cancer survivor from the time of 
diagnosis through the duration of his or her life (ACS, 2016).  
Unfortunately, many post-treatment cancer survivors have an array of ongoing mental 
and physical health needs due to their cancer or its treatment. Many of these needs can be 
addressed through public health interventions that concentrate on tobacco use (National Cancer 
Institute [NCI], 2014), physical activity, nutrition (Rock et al., 2012), and emotional well-being 
(Salvatore, Ahn, Jiang, Lorig, & Ory, 2015), which can help cancer survivors live longer and 
increase their quality of life. When assessing and planning for the needs of the cancer survivor 
population, it is important to note that this population tends to be older; in 2014, 88.2% of all 
cancers diagnosed in Michigan were in people 50 years of age or older. 
Public health has typically emphasized prevention and early detection, while the medical 
community has focused on treatment. Therefore, the ongoing needs of post-treatment cancer 
survivors are often overlooked. It has become essential for states and researchers to examine the 
public health needs of this growing population to promote their quality of life. In Michigan, data 
from the Michigan Cancer Surveillance Program (MCSP) and the 2015 Michigan Behavioral 
Risk Factor Survey (MiBRFS) in conjunction with cancer survivor focus groups were used to 
assist public health professionals understand the mental and physical health issues within this 
population. 
  
Methods 
 
Review of Existing Data. The MCSP is a central Cancer Registry that was established by state 
law (Act 82 of 1984) to collect reports on cases for in situ and invasive malignancies diagnosed 
throughout the state. The Cancer Registry provides a basis for cancer surveillance. Data on 
cancer incidence and mortality are available for the years 1985 to 2014 (Michigan Cancer 
Surveillance Program [MCSP], 2018).  
The MiBRFS is an annual statewide phone survey of Michigan adults aged 18 years and 
older coordinated with the Centers for Disease Control and Prevention (CDC). It includes a 
standard questionnaire, which states can customize to target and collect data from specific 
populations. In 2015, the Michigan Department of Health and Human Services (MDHHS) 
Cancer Prevention and Control Section’s Cancer Survivorship Program added a cancer 
survivorship module to the MiBRFS that consisted of 13 questions. Prevalence of cancer 
survivorship was defined as ever being told by a doctor, nurse, or other health professional that 
you had skin cancer or any other type of cancer. For those who were identified as a cancer 
survivor during the survey, the survivorship module was administered. The module included 
questions about treatment, post-cancer care, participation in clinical trials, and pain. The results 
of these questions were used to determine the prevalence of cancer survivors and analyze 
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relevant characteristics of this population. Additional analyses were performed using questions 
from the core questionnaire to better understand the behaviors and physical and mental health 
amongst cancer survivors. Prevalence estimates and 95% confidence intervals were calculated 
using SAS-Callable SUDAAN (version 11.0.1) (Michigan Behavioral Factor Surveillance 
System [MiBRFSS], 2018).   
 
Cancer Survivor Focus Groups. To increase the scope of understanding about challenges 
survivors face, focus groups were conducted. To assist in the development of these focus groups, 
cancer experts were recruited from the Michigan Cancer Consortium Cancer Survivorship 
Workgroup membership roster. This group brainstormed potential needs of cancer survivors 
which were then categorized to identify overall themes for use in the cancer survivor focus 
groups.   
 Seven cancer survivor focus groups were held: four urban groups from Ann Arbor, MI, 
one rural group from Traverse City, MI, and two rural groups from Cadillac, MI. These locations 
were selected based on previously existing MDHHS contracts addressing cancer survivorship.   
The contracted health systems were instructed to recruit survivors who were post-
treatment, although length of time since treatment was not a consideration. The groups were 
open to anyone who had been diagnosed with cancer in their lifetime and had completed initial 
treatment, or who were receiving long term treatment for cancer. Participants included both 
white and African American survivors, however; because of the size of these groups it was 
determined that comparisons by race could not be made. Focus groups had between two and ten 
participants and were not recorded but were conducted with two note-takers. The focus groups 
included four activities and were coded for themes. See Table 1 for information on each activity. 
While the MiBRFS, MCSP, and focus groups, are three distinct data resources which are 
independent from one another each one provides a different perspective on cancer survivorship. 
The subsequent analysis examines how these resources can complement each other and enhance 
the understanding of cancer survivorship. Conclusions were drawn by noting where the 
quantitative data can supplement the qualitative data gained from the focus group and where 
these data resources provide unique information.  
 
Results 
 
Cancer is the second leading cause of death in Michigan with 20,347 Michigan residents dying 
from cancer in 2015. In 2014, there were 438.2 new diagnoses of cancer per 100,000 Michigan 
residents, totaling 52,704 new cases of invasive cancer. From 1985 to 2014, 86.4% of cancer 
patients in the registry had only one cancer diagnosis. For all cases diagnosed in 2005, the 
Cancer Registry reports a 64.1% survival rate. In the 2015 MiBRFS, 10.0% of Michigan 
residents age 18 and older reported ever being told they have cancer. Table 2 shows 
demographics for the age-adjusted cancer survivor population in Michigan. Among MiBRFS 
respondents, 38% reported being first diagnosed with cancer at age 60 or older. In comparison, 
the Cancer Registry reports 68.6% of cases who were diagnosed in 2014 were diagnosed at age 
60 or older. The MiBRFS and the Cancer Registry provide essential resources when reviewing 
cancer survivorship, however they have limitations in terms of the data that they provide. The 
discrepancy between the Cancer Registry and MiBRFS sources are likely due, in part, to survivor 
bias. The MiBRFS only surveys people who are alive and healthy enough to complete the phone 
interview and does not accept proxy responses. Because of this, the needs of severely ill or 
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disabled survivors may not be captured in these data. Additionally, the MiBRFS asks for the age 
of the first cancer diagnosis and some respondents may have had a second diagnosis at a later 
age.  
Statistical differences were seen in cancer survivorship among subgroups including: 
gender, race, education, and employment. Among MiBRFS respondents, 10.9% of females and 
9.3% of males reported being cancer survivors. Non-Hispanic Blacks had the lowest percentage 
of cancer survivors (5.4%) compared to non-Hispanic Whites (11.0%), and Other and multi-
racial respondents (6.9%). Results for Hispanics or Latinos were suppressed due to having too 
few respondents. Significant differences existed in employment status; 12.6% of non-working 
individuals reported being a cancer survivor compared to 10.5% of employed individuals.  
Three major themes were identified from the focus groups based off responses to specific 
questions: health care, health-related behaviors, and social/emotional support; three sub-themes 
related to health care needs were then identified and are shown in Figure 1. Where available, 
MBRFS prevalence data was compared to these focus group themes.   
The first theme relates to the survivors’ experiences in seeking a physician post-cancer; 
cancer survivors are often seen by more than one physician for their medical care. According to 
the MiBRFS, 51.9% of survivors reported receiving any type of instructions on where to go for 
post-cancer care, and 40.5% of survivors had those instructions given to them as a written 
summary. With just over 50% of survivors reporting receiving follow-up instructions, it is not 
surprising that focus groups survivors reported being unsure of what questions to ask which 
doctors.  Survivors reported that, at times when they would ask a doctor a question, they would 
be told to ask a different doctor their question. Supportive and understanding medical care staff 
were viewed as important by the focus groups for improving the medical experience for all 
survivors.  
The second health care theme centered on the primary care provider’s ability to properly 
care for cancer survivors. In the MiBRFS, 84.0% of cancer survivors reported seeing a physician 
for routine care within the last year. This is important as 29.9% of survivors reported their 
general health as poor. Among cancer survivors who were at least three months post cancer 
treatment, 58.8% reported they receive their primary care from a Primary Care Physician (PCP). 
Those who did not see a PCP reported seeing an oncologist, surgeon, or another type of 
physician for their primary care. In the focus groups, survivors noted their PCP was not always 
aware of current screening practices and long-term effects of cancer treatments. 
The third health care sub-theme centered on finances. In the MiBRFS, 10.3% of cancer survivors 
reported that they needed to see a doctor but could not because of cost and 19.8% of cancer 
survivors reported that they were paying medical bills related to their cancer treatment over time. 
This question was not asked in the 2015 MiBRFS. Focus group participants reported that 
insurance did not always cover treatment for side-effects and that medical bills and copays were 
a challenge to pay. Some survivors simply reported that they needed money, with no 
qualifications about the underlying need for the money. Medical bills and disputes with 
insurance companies over cancer treatment coverage were also cited as a source of stress that 
survivors believed interrupted the healing process. 
Nutrition has long been a prime focus for public health interventions. Experts recommend 
that everyone eat at least five servings of fruits and vegetables per day. In the MiBRFS, only 
15.9% of cancer survivors reported eating at least five servings of fruits and vegetables every 
day. Adopting healthy behaviors post-cancer was also a theme in the focus groups. Education on 
proper nutrition and what to eat to stay healthy was one need identified by survivors. Suggested 
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nutritional-related resources mentioned by the focus groups included meal delivery and 
nutritional resources tailored to cancer survivors.  
The promotion of physical activity is another area common to public health. However, in 
the MiBRFS, 42.0% of cancer survivors reported being limited in activities due to a physical, 
mental, or emotional problem and 34.3% had a Body Mass Index classified as obese. The loss of 
common activities (e.g. golf) was a concern for some focus group participants. Cancer survivors 
in the focus groups were interested in resources for things like rehabilitation, adapted exercise 
classes, and complementary therapies (e.g. yoga and massage) to assist them with staying 
engaged with favorite leisure activities or to improve their health. Figure 2 provides the 
prevalence of these health-related behaviors among cancer survivors. 
From the MiBRFS, 11.3% of cancer survivors report having poor mental health (Figure 
2). All the focus groups discussed the need for additional social and emotional help. Survivors 
discussed not only body image issues, but the need for help with depression from loss of work, 
issues around identity, and self-image. Additionally, all focus groups discussed fear of cancer 
recurrence as a major source of anxiety. Support groups with other cancer survivors who are 
post-treatment were identified as a resource that could be helpful in addressing mental health 
issues. Individual counseling was another suggested resource. Family support was also discussed 
with many survivors stating that cancer is a family disease that can change a family dynamic and 
cause caregiver fatigue. As seen in our focus group, mental health support is a large need 
amongst the cancer survivor population and their families; however, quantitative data on this 
topic is limited because these needs are too specific for a general population surveillance system. 
There were issues discussed in focus groups that are currently not measured by a 
surveillance system. For example, sexual function was a very common theme. Some of this 
related to changes in body image and some of it related to changes in body function. This 
demonstrates the importance of combining surveillance activities with activities like focus 
groups to understand the full range of cancer survivor needs.  
The focus groups demonstrated a difference between urban and rural participants. While 
rural survivors only mentioned transportation as a concern when they had to travel several hours 
for second opinions, urban survivors mentioned transportation was an ongoing concern due to 
high traffic in urban areas. Rural groups also reported greater concerns around PCP training in 
regards to post-cancer care than the four urban groups. 
The importance of surveillance data was demonstrated by the fact that smoking was 
never brought up amongst survivors in the focus group. However, smoking prevalence is a 
common public health concern for those working within the cancer survivor community. From 
the MiBRFS, the prevalence of smoking among cancer survivors has decreased from 19.0% in 
2011 to 12.3% in 2016 (data not shown). In 2015, 71.3% of cancer survivors who were current 
smokers reported they had been advised or referred to resources to stop smoking. 
 
Conclusions 
 
The availability and usefulness of surveillance data in cancer survivorship has often been 
overlooked. Surveillance data on cancer survivorship can assist us in understanding the 
population and measuring the impact of public health interventions. However, surveillance has 
some limitations. First, there are questions that are not appropriate for a telephone survey (i.e., 
sexual functioning). Second, due to the number of people interviewed who report a history of 
cancer (N=1,433), some results from questions specific to survivorship cannot be analyzed 
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because there are too few respondents. The small sample size of cancer survivors is also an issue 
when trying to examine disparities amongst certain sub-populations. Given these limitations, it is 
important to seek the direct input of cancer survivors through activities like focus groups.  
By including cancer survivors in the discussion surrounding their own needs, public 
health organizations can ensure that their programs are more successful by encompassing 
important survivorship concerns that may not have emerged in typical surveillance sources. This 
will become increasingly important as the number of survivors grow. Questions that cannot be 
asked in a typical survey, such as sexual functioning, can often be overlooked in public health 
initiatives as there is limited data. Therefore, it is imperative that providers and public health 
professionals use not only the data available to them, but also the experiences of survivors to 
have a more complete outline of the public health need. 
In 2012, the Michigan Cancer Consortium, the Michigan Department of Health and 
Human Services, and the Michigan Oncology Quality Consortium started a public health 
intervention to decrease the prevalence of smoking in cancer survivors. Through a policy and 
system change model, oncologists now refer their patients who smoke to cessation services. Data 
obtained from the Michigan Behavioral Risk Factor Surveillance System demonstrates that there 
has been a statistically significant reduction in the number of current smokers in our survivor 
population (2011 to 2015) (data not shown). The success of this intervention suggests that other 
coordinated initiatives should be identified to frame other public health topics.  
 There are many ways that surveillance data can assist public health agencies in 
understanding cancer survivor needs. This is especially important because, as expressed from the 
focus groups, this growing group of cancer survivors often feel that their needs are still unmet. 
One of the most consistent messages that came out of the focus groups was appreciation for the 
focus group itself. As a whole, the focus group participants reported that “no one ever asks us 
what we need”. Therefore, it is crucial that public health professionals should not merely analyze 
data, but also seek the input of the communities which they serve, especially in areas that are not 
adequately assessed through surveillance measures.    
 It should be noted that survivorship is experienced differently by all survivors. However, 
due to small numbers in some populations, comparisons between specific demographic groups 
cannot be made with the data from the Michigan Behavioral Risk Factor Surveillance System. 
As the survivorship module questions are asked in the coming years, results will be combined 
with the data reported in this paper to give a better understanding of how survivorship is 
experienced by various populations. Conclusions and comparisons regarding how survivorship is 
experienced by different races were also limited in the focus groups. Survivors were recruited by 
currently contracted health systems who were limited in their recruitment due to the 
demographics that they serve. Additional focus groups will be necessary to understand how race 
may impact survivorship.   
Using a wide-range of data, providers and public health workers can continue to address 
cancer survivor needs throughout the cancer-care continuum. The need for public health 
programming and provider interventions surrounding cancer survivorship will continue to grow 
as the population of survivors increases. By using surveillance data, along with focus groups, 
public health organizations can more accurately target the needs of their survivorship program 
participants and measure programmatic outcomes.  
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Table 1: Summary of Survivor Focus Group Activities 
Activity 1: Ice Breaker 
Prompt given: Methods: Outcome: 
Who lives in your household? Verbal Number of household members 
Name one activity you like to do 
in your free time.  
Verbal Not recorded 
Activity 2: Now vs. Then 
Prompt given: Methods: Outcome: 
Thinking about your cancer 
diagnosis, think of three words 
that describe something that is 
different now as a cancer survivor 
versus before your diagnosis. 
• Focus group members were 
asked to write on index cards 
for moderator to collect. 
• Moderator wrote down all 
words on the board. 
• Identify reoccurring themes and 
ideas. 
• Note any disagreements. 
Activity 3: Needs 
Prompt given: Methods: Outcome: 
Thinking about your experience 
as a cancer survivor, think about 
the kinds of things you need now. 
• Focus group members were 
asked to write each need on a 
sticky note and categorize 
them under a theme. 
• Themes were previously 
identified by cancer experts 
and included: educational 
needs, health care needs, 
financial needs, resources, 
assessment needs, 
social/emotional, physical 
needs, new needs, other.  
• Identify reoccurring themes and 
ideas. 
• Note any disagreements. 
• Note needs that do not fit in 
any of the pre-identified 
themes. 
Activity 4: Surprises 
Prompt given: Methods: Outcome: 
We are now going to focus on 
things about cancer that have 
surprised you. What things have 
surprised you about being a 
cancer survivor? 
• As a group, members were 
asked to identify 15 things that 
were surprising. 
• Identify needs that were not 
mentioned in the previous 
activity. 
• Note agreements or 
disagreements about surprises. 
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Table 2: Characteristics of Participants from the 2015 Michigan Behavioral Risk Factor Survey 
who reported being a cancer survivor (Age-Adjusted) 
 
NOTE:  
a 
Cancer 
survivor is defined as responding ‘Yes’ to either “Have you ever been told you have skin cancer” or “Have 
you ever been told you have any other type of cancer” 
 b Prevalence estimate suppressed due to having a standard error of greater than 30% 
c Estimates are not age adjusted  
d  Represents the age of the respondent at the time of the survey 
  
Cancer Survivors a Percent  95% Confidence Interval 
Overall Michigan 10.0 (9.4, 10.6) 
Female 10.9 (10.0, 11.8) 
Male 9.3 (8.5, 10.2) 
Non-Hispanic White 11.0 (10.3, 11.8) 
Non-Hispanic Black 5.4 (4.2, 6.9) 
Hispanic or Latino b Suppressed Suppressed 
Other and multi-racial, non-Hispanic 6.9 (4.7, 10.0) 
Less than $20,000 9.9 (8.2, 11.9) 
$20,000 to $34,999 10.1 (8.6, 11.8) 
$35,000 to $49,999 10.8 (9.1, 12.9) 
$50,000 to $74,9999 9.8 (8.4, 11.3) 
$75,000 or more 10.9 (9.7, 12.2) 
Less than high school diploma 7.5 (5.7, 9.9) 
High school diploma or GED 9.4 (8.4, 10.4) 
Some college or Trade School 10.8 (9.7, 12.0) 
College graduate or higher 11.4 (10.4, 12.5) 
Employed 9.5 (8.2, 11.1) 
Unemployed 10.2 (7.2, 14.2) 
Non-working 11.9 (10.6, 13.2) 
Married 10.7 (9.8, 11.7) 
Formerly married 9.3 (7.4, 11.6) 
Never married 8.3 (6.3, 10.9) 
Widowed 15.8 (11.0, 22.3) 
Veteran 11.3 (9.1, 14.0) 
Homosexual or Bisexual 11.1 (6.9, 17.3) 
18 to 39 c,d 2.0 (1.4, 2.7) 
40 to 54 c,d 7.2 (6.1, 8.5) 
55 to 69 c,d 18.0 (16.5, 19.7) 
70 and Older c,d 19.4 (14.8, 25.0) 
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Figure 1: Prevalence of Health Care Utilization among Cancer Survivors, 2015 Michigan 
Behavioral Risk Factor Survey a 
 
 
NOTE:  a Cancer survivor is defined as responding ‘Yes’ to either “Have you ever been told you have skin cancer” 
or “Have you ever been told you have any other type of cancer” 
Figure 2: Prevalence of Health-Related Behaviors among Cancer Survivors, 2015 Michigan 
Behavioral Risk Factor Survey a 
 
NOTE:  a Cancer survivor is defined as responding ‘Yes’ to either “Have you ever been told you have skin cancer” 
or “Have you ever been told you have any other type of cancer” 
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